Stat News

The cannabis industry is scaling back its lobbying presence in Washington, facing financial woes due to marijuana's ongoing status of federal illegality. Major players like Curaleaf Holdings Inc (OTCQX: CURLF) have been compelled to slash their lobbying budgets by 40% in the first...

Blood plasma and diagnostics company Grifols SA (NASDAQ: GRFS) is set to completely acquire Alkahest Inc, a biopharmaceutical startup focussed on neurodegenerative and age-related diseases, for $146 million on a debt-free basis. What Happened: Grifols will buy the remaining equity in Alkahest...

Telemedicine company MDLive is planning for a public offering early next year, CEO Charles Jones told Stat Thursday. What Happened The executive disclosed that the offering is still in early stages and is planned for January or February next year, according to Stat. Jones said his decision to take...

Shares of Moderna Inc (NASDAQ: MRNA), a frontrunner in the race for a coronavirus vaccine, tumbled Thursday afternoon after a STAT News report suggested there could be a delay in the initiation of a late-stage study. Moderna's July Start In Doubt: Moderna's Phase 3 trial of...

Moderna, Inc.’s (NASDAQ: MRNA) claims on achieving a dose-dependent increase in immunogenicity in Phase 1 trials of its COVID-19 vaccine candidate, mRNA-1273, are not backed by sufficient data, according to vaccine experts.  The Curious Case Of Antibodies Moderna made claims on Monday...

Amarin Corporation plc (NASDAQ: AMRN) shares were falling Monday following the presentation of detailed primary results from the the late-stage REDUCE-IT study that evaluated Vascepa, held at a late-breaking session at the 2018 Scientific Sessions of the American Heart Association in Chicago....

Alkermes Plc (NASDAQ: ALKS) shares were trading down Friday as the Street weighed reports of regulatory setbacks for the biopharma.  What Happened The Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee...

On Friday's PreMarket Prep trading show, STAT News senior writer Adam Feuerstein weighed in on the results from Biogen Inc (NASDAQ: BIIB) and Eisai's Alzheimer's therapy candidate BAN2401. While BAN2401 failed to show a significant difference from a placebo in a 12-month Phase 2...

Crispr Therapeutics AG (NASDAQ: CRSP) plunged more than 14 percent Monday after Nature Medicine published two studies warning that CRISPR-Cas9 might actually trigger cancer rather than treat targeted diseases. The research was separately reported by the Karolinska Institute and Novartis AG (ADR) (...

AT&T Inc. (NYSE: T), Novartis AG (ADR) (NYSE: NVS) and Korea Aerospace Industries, a current collaborator with Lockheed Martin Corporation (NYSE: LMT) reportedly made payments to a shell company run by President Donald Trump’s personal lawyer. Why It’s Notable Michael Cohen’...

Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company that mostly focuses on developing therapies for the treatment of complement-mediated diseases and disorders of the central nervous system, saw its stock soar nearly 40 percent Thursday morning. What Happened American...

Shares of Gilead Sciences, Inc. (NASDAQ: GILD) appear to be unaffected by reports that call into question the safety of hepatitis C drugs. The stock was trading higher by 0.47 percent at $72.25 ahead of Thursday's stock market open. According to Stat News, reports were filed with the U.S. Food and...